Asuragen Launches Mirna Therapeutics™

View Press Release


miRNA microRNA Therapeutics
Learn more about Mirna Therapeutics

Related Publications:

  • Oncogene
  • MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma


  • PNAS
  • miR-15 and miR-16 induce apoptosis by targeting BCL2


  • Nature

    A microRNA polycistron as a potential human oncogene


  • Cell
  • RAS Is Regulated by the let-7 MicroRNA Family


About microRNAs


Find out why miRNAs make good therapeutics. Download


Delivering on the Promise of microRNA Therapeutics
Like antisense oligonucleotides, siRNAs, and other oligonucleotide-based drugs, miRNAs do not freely diffuse into cells and thus require assistance to enter disease cells.Therapeutic applications of miRNAs will benefit significantly from the on-going efforts of Novartis, Merck, Alnylam, Sirna, and others who are developing technologies that facilitate the use of siRNAs as therapeutics. Learn More


Onco-miRs™ RNA-based Therapeutics

Download information on microRNAs and cancer Learn more